DPP4 and plasma cell myeloma: On the other hand, despite the upregulation of CD26 expression in KMS11, its cytotoxic effect was not sufficiently observed following treatment with several class I/II or class I HDACi, suggesting that the upregulation of CD26 in myeloma cells was not necessarily correlated with anti-myeloma cytotoxicity by HDACi.